SAShun-Ichi Ariizumi

Shun-Ichi Ariizumi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shun-Ichi Ariizumi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Favorable long‐term surgical outcomes of hepatocellular carcinoma in patients with hepatitis B envelope antibody

    by Shun‐Ichi Ariizumi, Yoshihito Kotera, Satoshi Katagiri, Masakazu Yamamoto

    Background Surgical outcome of patients with hepatocellular carcinoma (HCC) in relation to the serum hepatitis B envelope (HBe) has not been clarified in detail. Methods We retrospectively studied 732 patients with HCC within the Milan criteria who underwent hepatectomy from 1991 through 2005. Serum hepatitis B surface antigen (HBs‐Ag) and hepatitis C virus (HCV) antibody were routinely performed preoperatively, and 92 patients were only positive for HBs‐Ag. Serum HBe antibody (HBe‐Ab) was further examined, and surgical outcomes after hepatectomy were compared with those of 70 patients who were positive for HBe‐Ab and 15 patients who were negative for HBe‐Ab. Results The 5‐ and 10‐year survival rates were significantly greater in patients who were positive for HBe‐Ab (90% and 80%, respectively) than in patients who were negative for HBe‐Ab (61% and 37%: P = 0.0004, respectively). The 5‐year recurrence‐free survival rate was significantly greater in patients who were positive for HBe‐Ab (53%) than in patients who were negative for HBe‐Ab (21%: P = 0.0054). Multivariate analysis showed that positive HBe‐Ab was an independent prognostic factor for survival (P = 0.0045) and recurrence‐free survival (P = 0.004). Conclusions Favorable long‐term surgical outcomes were achieved in patients with HCC within the Milan criteria who were positive for HBe‐Ab. J. Surg. Oncol. 2010; 101:471–475.

  • Right Hepatectomy for Hepatocellular Carcinoma in Patients with an Indocyanine Green Retention Rate at 15 Minutes of 10% or Higher

    by Shun-Ichi Ariizumi, Masakazu Yamamoto, Ken Takasaki

    Background/Aims: Liver failure after right hepatectomy for hepatocellular carcinoma (HCC) in patients with an indocyanine green retention rate at 15 min (ICGR15) of 10% or higher remains a controversial issue. Methods: Between 1995 and 2004, 98 patients with an ICGR15 of 10% or higher were scheduled to undergo right hepatectomy or tri-sectionectomy for HCC. The hepatic resection volume (HR) excluding the tumor was measured using computed tomography. The allowable HR (AHR) was determined in each patient with a logarithmic graph based on the ICGR15 and the %HR. Liver failure and mortality were evaluated between 54 patients with HR ≤ AHR (low-risk group) and 44 patients with HR > AHR (high-risk group). Results: The number of patients with liver failure was significantly lower in the low-risk group (2%) than in the high-risk group (23%, p = 0.0021). No mortality was observed in the low-risk group, while mortality was seen in the high-risk group (11%, p = 0.016). Multivariate analysis showed that the high-risk group was identified as a significant predictor of liver failure (p = 0.011). Conclusions: In patients with an ICGR15 of 10% or higher, determination of AHR is useful to predict liver failure prior to right hepatectomy or tri-sectionectomy.


  • Sectionectomy Is Suitable for Patients with T2 Hepatocellular Carcinoma according to the Modified International Union against Cancer TNM Classification

    by Shun-Ichi Ariizumi, Satoshi Katagiri, Hideo Katsuragawa, Yoshihito Kotera, Masakazu Yamamoto

    Background/Aims: The effectiveness of systematized hepatectomy in the modified International Union Against Cancer (UICC) staging classification for hepatocellular carcinoma (HCC) has not been clarified in detail. Methods: We retrospectively studied 406 patients with UICC T1 HCC and 124 patients with T2 HCC who underwent initial curative hepatectomy from 1994 through 2003. Outcomes after sectionectomy or larger resection and segmentectomy or smaller resection for patients with T1 HCC and T2 HCC were examined. Results: The overall recurrence-free survival rate and survival rate of sectionectomy or larger resection at 5 years (45 and 79%, respectively) did not significantly differ from those of segmentectomy or smaller resection (38 and 81%, respectively) in patients with T1 HCC. However, in patients with T2 HCC, the 5-year recurrence-free survival rate and survival rate after sectionectomy or larger resection (37 and 71%, respectively) were significantly different from those after segmentectomy or smaller resection (6%: p < 0.0001, and 35%: p = 0.0027, respectively). Multivariate analysis showed sectionectomy or larger resection to be a significant independent prognostic factor for recurrence-free survival and survival in patients with T2 HCC. Conclusions: Sectionectomy or larger resection prevents intrahepatic recurrence of HCC and prolongs survival in patients with T2 HCC.


  • Surgical Shunt Closure via the Lumen of an Intrahepatic Portal Aneurysm

    by S. Ariizumi, K. Takasaki, M. Yamamoto, H. Katsuragawa, S. Katagiri, K. Yoshitoshi, Y. Kotera

    Background/Aims: A surgical shunt closure via the lumen of an intrahepatic portal aneurysm was successfully performed in a 70-year-old Japanese woman with hepatic encephalopathy due to hyperammonemia. She had a 4-month history of repeated hepatic encephalopathy which persisted after treatment with oral medicine. Color Doppler ultrasonography and computed tomography revealed a cystic peripheral portal aneurysm, 4 cm in diameter, connecting the posterior branch of the portal vein to the short hepatic vein in the right lobe. Methods: While performing the Pringle maneuver and clamping the inferior vena cava below the liver, the wall of the portal aneurysm was opened, and the site of inflow from the portal vein and the site of outflow to the hepatic vein via the lumen of the portal aneurysm were closed with interrupted sutures. Results: The patient’s postoperative course was uneventful, and she was discharged 12 days after surgery. 12 months after surgery, she had no recurrence of hyperammonemia or hepatic encephalopathy. Conclusion: Surgical shunt closure via the lumen of a portal aneurysm can be performed safely, easily, and completely with good vision.